BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 100 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $88,000 | +17.3% | 25,673 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $75,000 | +2400.0% | 26,173 | +4101.1% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 623 | +27.4% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 489 | +25.7% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 389 | -20.4% | 0.00% | – |
| Q3 2018 | $4,000 | +100.0% | 489 | +25.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 389 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 389 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -96.6% | 389 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $58,000 | +100.0% | 20,389 | +96.3% | 0.00% | 0.0% |
| Q1 2016 | $29,000 | +625.0% | 10,389 | +2570.7% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -96.4% | 389 | -94.7% | 0.00% | -100.0% |
| Q2 2015 | $110,000 | +214.3% | 7,389 | +90.0% | 0.00% | +100.0% |
| Q1 2015 | $35,000 | -18.6% | 3,889 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $43,000 | +48.3% | 3,500 | +16.7% | 0.00% | 0.0% |
| Q3 2014 | $29,000 | -23.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $38,000 | +375.0% | 3,000 | +200.0% | 0.00% | – |
| Q4 2013 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | -83.7% | 1,000 | -96.4% | 0.00% | -100.0% |
| Q2 2013 | $43,000 | – | 28,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |